Leveraging the cutting-edge TME toolkit

IMMUNO-ONCOLOGY INSIGHTS

Leveraging the cutting-edge TME toolkit

October 2022
Leveraging the cutting-edge TME toolkit
Download PDF

Review

Emerging characterization of the tumor-restraining subset of CAFs

Emerging characterization of the tumor-restraining subset of CAFs

Jamie Bates
22 October 2022
Read

Innovator Insight

Predicting patient response to immune-targeted therapies via interrogation of the tumor microenvironment

Predicting patient response to immune-targeted therapies via interrogation of the tumor microenvironment

Mark Uhlik, Dr Caroline Fong
19 December 2022
Read
Modulation of both tumor & T cell apoptosis to enhance CAR-T immunotherapy

Modulation of both tumor & T cell apoptosis to enhance CAR-T immunotherapy

Marco Ruella
19 December 2022
Read

Viewpoint

Immune modulatory vaccines: the safe way to inflame the tumor microenvironment & guide anti-cancer immunotherapies

Immune modulatory vaccines: the safe way to inflame the tumor microenvironment & guide anti-cancer immunotherapies

Mads Hald Andersen
13 October 2022
Read

Interview

Exploring approaches for tackling the complexity of the tumor microenvironment: multi-parametric methods, new biomarkers & serial testing

Exploring approaches for tackling the complexity of the tumor microenvironment: multi-parametric methods, new biomarkers & serial testing

Laura Benjamin, Mark Uhlik
2 November 2022
Read
Exploring the epigenetics of the TME

Exploring the epigenetics of the TME

Jesús M Paramio
5 October 2022
Read
Studying the tumor microenvironment under pressure

Studying the tumor microenvironment under pressure

Meenal Datta
24 August 2022
Read

Webinars

Predicting patient response to immune targeted therapies via interrogation of the TME

Predicting patient response to immune targeted therapies via interrogation of the TME

Mark Uhlik PhD, Caroline Fong MD
12 October 2022
Watch
Circulating tumor DNA as a predictive biomarker for immunotherapy response: from clinical trials to clinical practice

Circulating tumor DNA as a predictive biomarker for immunotherapy response: from clinical trials to clinical practice

M Krainock, A Tan, J Simmons
19 October 2022
Watch